Fadahunsi N, Petersen J, Metz S, Jakobsen A, Vad Mathiesen C, Silke Buch- Rasmussen A, et al
No, colitis is not listed as a recognised adverse effect in the Wegovy Summary of Product Characteristics approved by the MHRA or in clinical trial data
L-Glutathione the master antioxidant that switches melanin from dark eumelanin to lighter phaeomelanin, progressively brightening skin tone and reversing skin darkness
Among adults with type 2 diabetes and obesity (the primary populations receiving GLP-1-based therapy), baseline rates of back pain are particularly high due to biomechanical factors, inflammatory processes, and comorbid conditions
Prenatal exposure to organophosphates is associated with neurodevelopmental disturbances
The article states plainly that GLP-1 medications do not replace or reduce the need for disease-modifying antirheumatic drugs, and that immunosuppressants such as methotrexate, TNF inhibitors, and JAK inhibitors must continue during GLP-1 treatment